Improving Functional Capacity and Quality of Life in Parkinson’s Disease Patients through REAC Neuromodulation Treatments for Mood and Behavioral Disorders
Parkinson’s disease is a neurological disorder that affects both motor and non-motor functions, including depression, anxiety, and cognitive decline. Currently, it remains a challenge to distinguish the correlation between these aspects and their impact on one another. To try to clarify these recipr...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-06-01
|
| Series: | Journal of Personalized Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4426/13/6/937 |
| _version_ | 1797593962961174528 |
|---|---|
| author | Chiara Rinaldi Cleuton Braga Landre Maria Izabel Volpe Rebeca Góes Gonçalves Lucas dos Santos Nunes Danyela Darienso Ana Vitoria Cruz João Douglas Oliveira Salvatore Rinaldi Vania Fontani Ana Rita Barcessat |
| author_facet | Chiara Rinaldi Cleuton Braga Landre Maria Izabel Volpe Rebeca Góes Gonçalves Lucas dos Santos Nunes Danyela Darienso Ana Vitoria Cruz João Douglas Oliveira Salvatore Rinaldi Vania Fontani Ana Rita Barcessat |
| author_sort | Chiara Rinaldi |
| collection | DOAJ |
| description | Parkinson’s disease is a neurological disorder that affects both motor and non-motor functions, including depression, anxiety, and cognitive decline. Currently, it remains a challenge to distinguish the correlation between these aspects and their impact on one another. To try to clarify these reciprocal influences, in this study we have used specific radio electric asymmetric conveyer (REAC) technology neuromodulation treatments for behavioral mood disorders and adjustment disorders. In particular, we employed the neuro-postural optimization (NPO) and neuro-psycho-physical optimization (NPPOs) treatments. The study enrolled randomly 50 subjects of both genders previously diagnosed with Parkinson’s disease for at least six months. Prior to and following REAC NPO and NPPOs treatments, we assessed the subjects using functional dysmetria (FD) evaluation, five times sit to stand test (FTSST) for postural stability, and the 12-item Short-Form Health Survey (SF-12) for quality of life (QLF) evaluation. The positive results produced by the REAC NPO and NPPOs neuromodulation treatments, specific for mood and adaptation disorders, on dysfunctional motor disorders, and quality of life confirm how the non-motor components can condition the symptomatology of Parkinsonian motor symptoms. These results also highlight the usefulness of REAC NPO and NPPOs treatments in improving the overall quality of life of these patients. |
| first_indexed | 2024-03-11T02:16:57Z |
| format | Article |
| id | doaj.art-fb49b47eb30d4d9ca12a91a7cb274fce |
| institution | Directory Open Access Journal |
| issn | 2075-4426 |
| language | English |
| last_indexed | 2024-03-11T02:16:57Z |
| publishDate | 2023-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Personalized Medicine |
| spelling | doaj.art-fb49b47eb30d4d9ca12a91a7cb274fce2023-11-18T11:10:50ZengMDPI AGJournal of Personalized Medicine2075-44262023-06-0113693710.3390/jpm13060937Improving Functional Capacity and Quality of Life in Parkinson’s Disease Patients through REAC Neuromodulation Treatments for Mood and Behavioral DisordersChiara Rinaldi0Cleuton Braga Landre1Maria Izabel Volpe2Rebeca Góes Gonçalves3Lucas dos Santos Nunes4Danyela Darienso5Ana Vitoria Cruz6João Douglas Oliveira7Salvatore Rinaldi8Vania Fontani9Ana Rita Barcessat10Department of Neuroscience, Psychology, Drug Area, and Child Health (NEUROFARBA), University of Florence, 50121 Florence, ItalyDepartment of Biological and Health Sciences, Federal University of Amapá—UNIFAP, Macapá 68903-419, BrazilDepartment of Biological and Health Sciences, Federal University of Amapá—UNIFAP, Macapá 68903-419, BrazilDepartment of Biological and Health Sciences, Federal University of Amapá—UNIFAP, Macapá 68903-419, BrazilDepartment of Biological and Health Sciences, Federal University of Amapá—UNIFAP, Macapá 68903-419, BrazilDepartment of Biological and Health Sciences, Federal University of Amapá—UNIFAP, Macapá 68903-419, BrazilDepartment of Biological and Health Sciences, Federal University of Amapá—UNIFAP, Macapá 68903-419, BrazilDepartment of Biological and Health Sciences, Federal University of Amapá—UNIFAP, Macapá 68903-419, BrazilDepartment of Regenerative Medicine, Rinaldi Fontani Institute, 50144 Florence, ItalyDepartment of Regenerative Medicine, Rinaldi Fontani Institute, 50144 Florence, ItalyGraduate Program in Health Sciences—PPGCS, Federal University of Amapá—UNIFAP, Macapá 68903-419, BrazilParkinson’s disease is a neurological disorder that affects both motor and non-motor functions, including depression, anxiety, and cognitive decline. Currently, it remains a challenge to distinguish the correlation between these aspects and their impact on one another. To try to clarify these reciprocal influences, in this study we have used specific radio electric asymmetric conveyer (REAC) technology neuromodulation treatments for behavioral mood disorders and adjustment disorders. In particular, we employed the neuro-postural optimization (NPO) and neuro-psycho-physical optimization (NPPOs) treatments. The study enrolled randomly 50 subjects of both genders previously diagnosed with Parkinson’s disease for at least six months. Prior to and following REAC NPO and NPPOs treatments, we assessed the subjects using functional dysmetria (FD) evaluation, five times sit to stand test (FTSST) for postural stability, and the 12-item Short-Form Health Survey (SF-12) for quality of life (QLF) evaluation. The positive results produced by the REAC NPO and NPPOs neuromodulation treatments, specific for mood and adaptation disorders, on dysfunctional motor disorders, and quality of life confirm how the non-motor components can condition the symptomatology of Parkinsonian motor symptoms. These results also highlight the usefulness of REAC NPO and NPPOs treatments in improving the overall quality of life of these patients.https://www.mdpi.com/2075-4426/13/6/937Parkinsonmotor symptomsnon-motor symptomsmood and behavioral disordersneuromodulationradio electric asymmetric conveyer technology |
| spellingShingle | Chiara Rinaldi Cleuton Braga Landre Maria Izabel Volpe Rebeca Góes Gonçalves Lucas dos Santos Nunes Danyela Darienso Ana Vitoria Cruz João Douglas Oliveira Salvatore Rinaldi Vania Fontani Ana Rita Barcessat Improving Functional Capacity and Quality of Life in Parkinson’s Disease Patients through REAC Neuromodulation Treatments for Mood and Behavioral Disorders Journal of Personalized Medicine Parkinson motor symptoms non-motor symptoms mood and behavioral disorders neuromodulation radio electric asymmetric conveyer technology |
| title | Improving Functional Capacity and Quality of Life in Parkinson’s Disease Patients through REAC Neuromodulation Treatments for Mood and Behavioral Disorders |
| title_full | Improving Functional Capacity and Quality of Life in Parkinson’s Disease Patients through REAC Neuromodulation Treatments for Mood and Behavioral Disorders |
| title_fullStr | Improving Functional Capacity and Quality of Life in Parkinson’s Disease Patients through REAC Neuromodulation Treatments for Mood and Behavioral Disorders |
| title_full_unstemmed | Improving Functional Capacity and Quality of Life in Parkinson’s Disease Patients through REAC Neuromodulation Treatments for Mood and Behavioral Disorders |
| title_short | Improving Functional Capacity and Quality of Life in Parkinson’s Disease Patients through REAC Neuromodulation Treatments for Mood and Behavioral Disorders |
| title_sort | improving functional capacity and quality of life in parkinson s disease patients through reac neuromodulation treatments for mood and behavioral disorders |
| topic | Parkinson motor symptoms non-motor symptoms mood and behavioral disorders neuromodulation radio electric asymmetric conveyer technology |
| url | https://www.mdpi.com/2075-4426/13/6/937 |
| work_keys_str_mv | AT chiararinaldi improvingfunctionalcapacityandqualityoflifeinparkinsonsdiseasepatientsthroughreacneuromodulationtreatmentsformoodandbehavioraldisorders AT cleutonbragalandre improvingfunctionalcapacityandqualityoflifeinparkinsonsdiseasepatientsthroughreacneuromodulationtreatmentsformoodandbehavioraldisorders AT mariaizabelvolpe improvingfunctionalcapacityandqualityoflifeinparkinsonsdiseasepatientsthroughreacneuromodulationtreatmentsformoodandbehavioraldisorders AT rebecagoesgoncalves improvingfunctionalcapacityandqualityoflifeinparkinsonsdiseasepatientsthroughreacneuromodulationtreatmentsformoodandbehavioraldisorders AT lucasdossantosnunes improvingfunctionalcapacityandqualityoflifeinparkinsonsdiseasepatientsthroughreacneuromodulationtreatmentsformoodandbehavioraldisorders AT danyeladarienso improvingfunctionalcapacityandqualityoflifeinparkinsonsdiseasepatientsthroughreacneuromodulationtreatmentsformoodandbehavioraldisorders AT anavitoriacruz improvingfunctionalcapacityandqualityoflifeinparkinsonsdiseasepatientsthroughreacneuromodulationtreatmentsformoodandbehavioraldisorders AT joaodouglasoliveira improvingfunctionalcapacityandqualityoflifeinparkinsonsdiseasepatientsthroughreacneuromodulationtreatmentsformoodandbehavioraldisorders AT salvatorerinaldi improvingfunctionalcapacityandqualityoflifeinparkinsonsdiseasepatientsthroughreacneuromodulationtreatmentsformoodandbehavioraldisorders AT vaniafontani improvingfunctionalcapacityandqualityoflifeinparkinsonsdiseasepatientsthroughreacneuromodulationtreatmentsformoodandbehavioraldisorders AT anaritabarcessat improvingfunctionalcapacityandqualityoflifeinparkinsonsdiseasepatientsthroughreacneuromodulationtreatmentsformoodandbehavioraldisorders |